Therapix Biosciences Ltd (TRPX) Stock Price & Overview

NASDAQ:TRPX

Current stock price

0.317
-0.3 (-48.9%)
At close:
0.305
-0.01 (-3.79%)
After Hours:

The current stock price of TRPX is 0.317 null. Today TRPX is down by -48.9%. In the past month the price decreased by -39.04%. In the past year, price decreased by -87.11%.

TRPX Key Statistics

52-Week Range0.2522 - 4.69
Current TRPX stock price positioned within its 52-week range.
1-Month Range0.3011 - 1.08
Current TRPX stock price positioned within its 1-month range.
Market Cap
1.113M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.04
Dividend Yield
N/A

TRPX Stock Performance

Today
-48.9%
1 Week
-55.28%
1 Month
-39.04%
3 Months
+4.72%
Longer-term
6 Months -69.77%
1 Year -87.11%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

TRPX Stock Chart

Therapix Biosciences Ltd / TRPX Daily stock chart

TRPX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to TRPX. When comparing the yearly performance of all stocks, TRPX is a bad performer in the overall market: 96.97% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
TRPX Full Technical Analysis Report

TRPX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to TRPX. Both the profitability and financial health of TRPX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TRPX Full Fundamental Analysis Report

TRPX Earnings

Next Earnings DateN/A
Last Earnings DateN/A
TRPX Earnings History

TRPX Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
TRPX Forecast & Estimates

TRPX Financial Highlights

Over the last trailing twelve months TRPX reported a non-GAAP Earnings per Share(EPS) of -1.04. The EPS increased by 57.38% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-4.79M
Industry RankSector Rank
PM (TTM) N/A
ROA -230.26%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)57.38%
Revenue 1Y (TTM)N/A
TRPX financials

TRPX Ownership

Ownership
Inst Owners0.79%
Shares3.51M
Float3.07M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
TRPX Ownership

About TRPX

Company Profile

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.

Company Info

Therapix Biosciences Ltd

4 ARIEL SHARON STREET HASHAHAR TOWER 16TH FLOOR

GIVATAYIM L3 5320047

CEO: Gilad Bar-Lev

Phone: 972-3616-7055

Therapix Biosciences Ltd / TRPX FAQ

What does TRPX do?

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to the high value and under-served market of mild cognitive impairment are in clinical stage. Therapix Biosciences Ltd is based in Tel Aviv, Israel.


Can you provide the latest stock price for Therapix Biosciences Ltd?

The current stock price of TRPX is 0.317 null. The price decreased by -48.9% in the last trading session.


What is the dividend status of Therapix Biosciences Ltd?

TRPX does not pay a dividend.


What is the ChartMill technical and fundamental rating of TRPX stock?

TRPX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Who owns Therapix Biosciences Ltd?

You can find the ownership structure of Therapix Biosciences Ltd (TRPX) on the Ownership tab.